Abstract
Oxidative modification of low density lipoprotein (LDL) is known to be a key event for induction of atherosclerosis. However, there has been little progress in structural elucidation of oxidized lipids, especially oxidatively fragmented phospholipids retaining a glycerol backbone. In this study, we found that LDL derived from egg yolk has no platelet-activating factor (PAF) acetylhydrolase activity, and that prolonged incubation of egg yolk LDL with Cu2+ resulted in the formation of various PAF-like lipids: 1-acyl type phosphatidylcholines with ansn-2-short-chain dicarboxylate or monocarboxylate group. Only a very small amount of the PAF-like lipid having ansn-2-short-chain monocarboxylate group was detected by gas chromatography-mass spectrometry in Cu2+-oxidized LDL from human plasma with high PAF-acetylhydrolase activity, which has been reported to hydrolyze PAF-like lipids to lysophosphatidylcholines. Preincubation of plasma LDL with diisopropyl fluorophosphate dose-dependently inhibited PAF-acetylhydrolase activity, resulting in accumulation of the PAF-like lipids when the LDL was oxidized with Cu2+. As well as PAF and lysophosphatidylcholines, several PAF-like lipids were found to inhibit [3H]thymidine incorporation into cultured vascular smooth muscle cells derived from rat aorta. The possible formation of PAF-like lipids by lipid peroxidation in LDL is discussed as well as its possible significance for induction of atherosclerosis.
Similar content being viewed by others
Abbreviations
- acylPAF:
-
1 long-chain acyl analogue of platelet- activating factor
- BSA:
-
bovine serum albumin
- DC:
-
short-chain dicarboxylate
- DFP:
-
diisopropyl fluorophosphate
- FAB-MS:
-
fast atom bombardment-mass spectrometry
- GC-MS:
-
gas chromatography-mass spectrometry
- GLC:
-
gas-liquid chromatography
- GPC:
-
sn-glycero-3-phosphocholine
- LDL:
-
low density lipoprotein
- lysoPAF:
-
lysoplatelet-activating factor
- lysoPC:
-
lysophosphatidylcholine
- MC:
-
short-chain monocarboxylate
- PAF:
-
platelet-activating factor
- PAF-AH:
-
platelet-activating factor acetylhydrolase
- PC:
-
phosphatidylcholine
- tBDMS:
-
tert-butyldimethylsilyl
- TLC:
-
thin-layer chromatography
- VSMC:
-
vascular smooth muscle cells
References
Braquet, P., Touqui, L., Shen, T.Y., and Vargaftig, B.B. (1989) Perspectives in Platelet-Activating Factor Research,Pharmacol. Rev. 39, 97–145.
Hanahan, D.J. (1986) Platelet Activating Factor: A Biologically Active Phosphoglyceride,Ann. Rev. Biochem. 55, 483–509.
Snyder, F. (1990) Platelet-Activating Factor and Related Acetylated Lipids as Potent Biologically Active Cellular Mediators,Am. J. Physiol. 259, C697-C708.
Sugiura, T., Yamashita, A., Kudo, N., Fukuda, T., Miyamoto, T., Cheng, N., Kishimoto, S., Waku, K., Tanaka, T., Tsukatani, H., and Tokumura, A. (1995) Platelet-Activating Factor and Its Structural Analogues in the EarthwormEisenia foetida, Biochim. Biophys. Acta 1258, 19–26.
Tokumura, A., Kamiyasu, K., Takauchi, K., and Tsukatani, H. (1987) Evidence for Existence of Various Homologues and Analogues of Platelet Activating Factor in a Lipid Extract of Bovine Brain,Biochem. Biophys. Res. Commun. 145, 415–425.
Tokumura, A., Asai, T., Takauchi, K., Kamiyasu, K., Ogawa, T., and Tsukatani, H. (1988) Novel Phospholipids with Aliphatic Dicarboxylic Acid Residues in a Lipid Extract from Bovine Brain,Biochem. Biophys. Res. Commun. 155, 863–869.
Tokumura, A., Tanaka, T., Yotsumoto, T., and Tsukatani, H. (1991) Identification ofsn-2-ω-Hydroxycarboxylate-Containing Phospholipids in a Lipid Extract from Bovine Brain,Biochem. Biophys. Res. Commun. 177, 466–473.
Tanaka, T., Minamino, H., Unezaki, S., Tsukatani, H., and Tokumura, A. (1993) Formation of Platelet-Activating Factor-Like Phospholipids by Fe2+/Ascorbate/EDTA-Induced Lipid Peroxidation,Biochim. Biophys. Acta 1166, 264–274.
Tanaka, T., Iimori, M., Tsukatani, H., and Tokumura, A. (1994) Platelet-Aggregating Effects of Platelet-Activating Factor-Like Phospholipids Formed by Oxidation of Phosphatidylcholines Containing ansn-2-Polyunsaturated Fatty Acyl Group,Biochim. Biophys. Acta 1210, 202–208.
Itabe, H., Kushi, Y., Handa, S., and Inoue, K. (1988) Identification of 2-Azelaoylphosphatidylcholine as One of the Cytotoxic Products Generated During Oxyhemoglobin-Induced Peroxidation of Phosphatidylcholine,Biochim. Biophys. Acta 962, 8–15.
Patel, K.D., Zimmerman, G.A., Prescott, S. M., and McIntyre, T.M. (1992) Novel Leukocyte Agonists Are Released by Endothelial Cells Exposed to Peroxide,J. Biol. Chem. 267, 15168–15175.
Esterbauer, H., Gebicki, J., Puhl, H., and Jürgens, G. (1992) The Role of Lipid Peroxidation and Antioxidants in Oxidative Modification of LDL,Free Radic. Biol. Med. 13, 341–390.
Watson, A.D., Navab, M., Hama, S.Y., Sevanian, A., Prescott, S.M., Stafforini, D.M., McIntyre, T.M., La Du, B.N., Fogelman, A.M., and Berliner, J.A. (1995) Effect of Platelet Activating Factor-Acetylhydrolase on the Formation and Action of Minimally Oxidized Low Density Lipoprotein,J. Clin. Invest. 95, 774–782.
Heery, J.M., Kozak, M., Stafforini, D.M., Jones, D.A., Zimmerman, G.A., McIntyre, T.M., and Prescott, S.M. (1995) Oxidatively Modified LDL Contains Phospholipids with Platelet-Activating Factor-Like Activity and Stimulates the Growth of Smooth Muscle Cells,J. Clin. Invest. 96, 2322–2330.
Kamido, H., Kuksis, A., Marai, L., and Myher, J.J. (1995) Lipid Ester-Bound Aldehydes Among Copper-Catalyzed Peroxidation Products of Human Plasma Lipoproteins,J. Lipid Res. 36, 1876–1886.
Tokumura, A., Takauchi, K., Asai, T., Kamiyasu, K., Ogawa, T., and Tsukatani, H. (1998) Novel Molecular Analogues of Phosphatidylcholines in a Lipid Extract from Bovine Brain: 1-Long-Chain Acyl-2-Short-Chain Acyl-sn-Glycero-3-Phosphocholines,J. Lipid Res. 155, 863–869.
Hatch, F.T., and Lees, R.S. (1968) Practical Methods for Plasma Lipoprotein Analysis,Adv. Lipid Res. 6, 1–68.
Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951) Protein Measurement with Folin Phenol Reagent,J. Biol. Chem. 193, 265–275.
Bligh, E.G., and Dyer, W.J. (1959) A Rapid Method of Total Lipid Extraction and Purification,Can. J. Biochem. Physiol. 37, 911–917.
Chalvarjian, A., and Rudnicki, E. (1970) Determination of Lipid Phosphorus in the Nanomolar Range,Anal. Biochem. 36, 225–226.
Tokumura, A., Iimori, M., Nishioka, Y., Kitahara, M., Sakashita, M., and Tanaka, S. (1994) Lysophosphatidic Acids Induce Proliferation of Cultured Vascular Smooth Muscle Cells from Rat Aorta,Am. J. Physiol. 267, C204-C210.
Cabot, M.C., Faulkner, L.A., Lackey, R.J., and Snyder, F. (1984) Vertebrate Class Distribution of 1-Alkyl-2-Acetyl-sn-Glycero-3-Phosphocholine Acetylhydrolase in Serum,Comp. Biochem. Physiol. 78B, 37–40.
Steinbrecher, U.P., and Prichard, P.H. (1989) Hydrolysis of Phosphatidylcholine During LDL Oxidation Is Mediated by Platelet-Activating Factor Acetylhydrolase,J. Lipid Res. 30, 305–315.
Stafforini, D.M., Zimmerman, G.A., McIntyre, T.M., and Prescott, S.M. (1993) The Platelet-Activating Factor Acetylhydrolase from Human Plasma Prevents Oxidative Modification of Low-Density Lipoprotein,Trans. Assoc. Amer. Phys. 105, 44–63.
Sugiyama, S., Kugiyama, K., Ohgushi, M., Fujimoto, K., and Yasue, H. (1994) Lysophosphatidylcholine in Oxidized Low-Density Lipoprotein Increases Endothelial Susceptibility to Polymorphonuclear Leukocytes-Induced Endothelial Dysfunction in Porcine Coronary Arteries. Role of Protein Kinase C,Circ. Res. 74, 565–575.
Liapikos, T.A., Antonopoulou, S., Karabina, S.P., Tsoukatos, D.C., Demopoulos, C.A., and Tselepis, A.D. (1994) Platelet-Activating Factor Formation During Oxidative Modification of Low-Density Lipoprotein When PAF-acetylhydrolase Has Been Inactivated,Biochim. Biophys. Acta 1212, 353–360.
Smiley, P.L., Stremler, K.E., Prescott,, S.M., Zimmerman, G.A., and McIntyre, T.M. (1991) Oxidatively Fragmented Phosphatidylcholines Activate Human Neutrophils Through the Receptor for Platelet-Activating Factor,J. Biol. Chem. 266, 11104–11110.
Tokumura, A. (1995) A Family of Phospholipid Autacoids: Occurrence, Metabolism and Bioactions,Prog. Lipid Res. 34, 151–184.
Stafforini, D.M., Carter, M.E., Zimmerman, G.A., McIntyre, T.M., and Prescott, S.M. (1989) Lipoproteins Alter the Catalytic Behavior of the Platelet-Activating Factor Acetylhydrolase in Human Plasma,Proc. Natl. Acad. Sci. U.S.A. 86, 2393–2397.
Stremler, K.E., Stafforini, D.M., Prescott, S.M., and McIntyre, T.M. (1991) An Oxidized Derivatives of Phosphatidylcholine Is a Substrate for the Platelet-Activating Factor Acetylhydrolase from Human Plasma,J. Biol. Chem. 264, 5331–5334.
Berliner, J.A., and Harberland, M.E. (1993) Role of Oxidized Low Density Lipoprotein in Atherogenesis,Curr. Opin. Lipidol. 4, 373–381.
Locher, R., Weisser, B., Mengden, T., Brunner, C., and Vetter, W. (1992) Lysolecithin Actions on Vascular Smooth Muscle Cells,Biochem. Biophys. Res. Communn. 183, 156–162.
Chen, Y., Morimoto, S., Kitano, S., Koh, E., Fukuo, K., Jiang, B., Chen, S., Yasuda, O., Hirotani, A., and Ogihara, T. (1995) Lysophosphatidylcholine Causes Ca2+ Influx, Enhanced DNA Synthesis and Cytotoxicity in Cultured Vascular Smooth Muscle Cells,Atherosclerosis 112, 60–76.
Chatterjee, S. (1992) Role of Oxidized Human Plasma Low Density Lipoproteins in Atherosclerosis: Effects on Smooth Muscle Cell Proliferation,Mol. Cell. Biochem. 111, 143–147.
Augé, N., Pieraggi, M.T., Thiers, J.C., Negre-Salvayre, A. and Salvayre, R. (1995) Proliferative and Cytotoxic Effects of Mildly Oxidized Low-Density Lipoproteins on Vascular Smooth-Muscle Cells,Biochem. J. 309, 1015–1020.
Author information
Authors and Affiliations
About this article
Cite this article
Tokumura, A., Toujima, M., Yoshioka, Y. et al. Lipid peroxidation in low density lipoproteins from human plasma and egg yolk promotes accumulation of 1-acyl analogues of platelet-activating factor-like lipids. Lipids 31, 1251–1258 (1996). https://doi.org/10.1007/BF02587909
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02587909